Opinion
The latest opinion pieces by industry thought leaders
If you are interested in having your voice heard on PharmaVoice's Opinion page, please read our editorial guidelines and fill out the submission form here.
-
Jemal Countess via Getty Images
The judicial microscope on abortion meds puts FDA and industry in a precarious spot
The recent SCOTUS case involving mifepristone exposes the risk of drug safety determinations by judicial fiat.
Meg Alexander • May 9, 2024 -
Stock via Getty Images
Pharma execs sound off on trends and policies they’re tracking in 2024
From regulatory concerns to leadership skills, pharma leaders at JPM shared how they’re approaching the coming year.
Meagan Parrish • Jan. 12, 2024 -
Stock via Getty Images
PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials
As advanced therapies and patient perspectives strengthen their foothold in R&D, pharma is poised to deliver impactful treatments in record time.
Meagan Parrish • Jan. 11, 2024 -
Stock via Getty Images
PharmaVoice’s Crystal Ball: Perspectives on the financial future
Industry leaders predict what it will take for pharma to defeat its financial foes in 2024.
Meagan Parrish • Jan. 9, 2024 -
Permission granted by NYU
The thorniest questions facing pharma, according to a leading bioethicist
Bioethics guru Arthur Caplan of NYU gives his outspoken and frank opinion on the industry’s minefield of ethical challenges.
Michael Gibney • Nov. 6, 2023 -
Stock via Getty Images
Branded: The trademarks pharma leaders look up to
What do brands like Patagonia, Nike and Lego have to do with pharma? Here are some of the brands industry leaders relate to most — and how they inspire work in the life sciences.
PharmaVoice Staff • Oct. 13, 2023 -
Stock via Getty Images
Shaking up pharma: Change that leaders would like to see
Industry execs give voice to the “game changers” they believe would have the greatest impact on the healthcare ecosystem for all.
Taren Grom • June 16, 2023 -
Stock via Getty Images
A key to ‘winning’ in today’s market — and other trends pharma leaders are tracking
Healthcare pros share the market drivers they believe are having the biggest impact on the industry.
Taren Grom • June 2, 2023 -
Permission granted by Rashmi Gupta Microsoft
The ‘superpowers’ pharma leaders should cultivate
Executives honored by the Healthcare Businesswomen’s Association share the key traits that help them drive results.
Taren Grom • May 26, 2023 -
Stock via Getty Images
How biopharma executives fight burnout
Pharma leaders share what they do to keep their teams from fizzling out.
Taren Grom • May 19, 2023 -
Stock via Getty Images
What pharma can teach biotech about the life cycle management of a drug
Global product teams are common in pharma but have yet to gain traction in biotech. Here's why this model can work.
Dr. Stephen Dale and Kathleen Ford • May 18, 2023 -
Stock via Getty Images
Leaders wave a magic wand at pharma’s thorniest issues
The major challenges pharma leaders would solve with a quick flick of an imaginary wand.
PharmaVoice staff • March 31, 2023 -
Stock via Getty Images
What would you fix with a ‘magic wand?’ Pharma leaders chime in about clinical trials
How life science execs would transform clinical trials with a little hocus pocus.
PharmaVoice staff • March 24, 2023 -
Stock via Getty Images
How biotechs can weather the market storm
Execs at JPM sound off on moves companies can make to survive the challenging market conditions.
Meagan Parrish • Jan. 13, 2023 -
Stock via Getty Images
The 2023 PharmaVoice Crystal Ball: Peering into the future of life sciences
A preview of the top trends on the minds of industry and market leaders for the new year.
Taren Grom • Jan. 3, 2023 -
Stock via Getty Images
WoW: What a year
A look back at some of the most inspirational quotes from the Women of the Week podcasts in 2022.
Taren Grom • Dec. 20, 2022 -
Stock via Getty Images
Healthcare tech’s biggest busts
The metaverse, blockchain, DCTs and more — here are some of the most recent fails in healthcare tech.
Taren Grom • Dec. 2, 2022 -
Stock via Getty Images
Hybrid work is here to stay — here’s how leaders should adjust
Executives across the life sciences share their tips for navigating the new norm of remote work.
Taren Grom • Nov. 18, 2022 -
iStock via Getty Images
Why the IRA will drive up the country’s drug bill — not lower it
On the surface, the Inflation Reduction Act is designed to lower drug prices, but its impact on innovation incentives could produce a landscape of new medicines that are costlier for patients.
John LaMattina • Nov. 14, 2022 -
Stock via Getty Images
Pharma execs on creating a better workplace culture
Top women execs speak to the leadership skills they are embracing as the industry adjusts to a new normal.
Taren Grom • Oct. 28, 2022 -
Stock via Getty Images
What’s keeping pharma leaders up at night
C-suite execs in the life sciences share their late-night thoughts including innovation, patient access and market factors.
Taren Grom • Oct. 21, 2022 -
Stock via Getty Images
What’s your leadership brand?
Pharma industry leaders share their brand personas.
Taren Grom • Oct. 14, 2022 -
Stock via Getty Images
Are you a bad boss?
Pharma execs share their tips for being a better leader.
Taren Grom • Oct. 7, 2022 -
Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma and one of this year's HBA Luminary honorees.
Why 'soft' skills matter in the new era of leadership
Standout leaders honored by the Healthcare Businesswomen's Association discuss the rising value of the interpersonal approach.
Taren Grom • May 12, 2022 -
Stock via Getty Images
Industry executives on the milestone moments shaping pharma's future
Scientific, technological, and communication changes that are making a permanent impact on the industry.
Taren Grom • Feb. 9, 2022
